Kinarus News | finanzen.ch

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Strukturierte Produkte

Aktion

Portfolio

Watchlist

01.03.24	Extraordinary General Meeting of Kinarus Holding approved all resolutions relating to the envisaged Business Combination with Curatis (EQS Group)
12.07.23	Kinarus Therapeutics Announces Personnel Changes (EQS Group)
29.06.23	Kinarus Therapeutics Shareholders Approve All Board Proposals at the 2023 Annual General Meeting (EQS Group)
02.06.23	Kinarus Therapeutics Publishes Invitation to the 2023 Annual General Meeting (EQS Group)
21.02.23	Kinarus Therapeutics Phase 2 KINFAST Covid-19 Clinical Trial Progress Update (EQS Group)
17.01.23	Kinarus Therapeutics Reports Preclinical Data in Lung Fibrosis and Discloses Clinical Development Plan (EQS Group)
06.12.22	Kinarus Therapeutics KIN001 Shows Strong Antiviral Activity Against SARS-CoV-2 Omicron Subvariants BA.2 and BA.5 (EQS Group)
22.11.22	Kinarus Receives USPTO Notice of Allowance for Lead Therapeutic Candidate KIN001 (EQS Group)
22.11.22	Kinarus Receives USPTO Notice of Allowance for Lead Therapeutic Candidate KIN001 (GlobeNewswire)
04.11.22	Kinarus Therapeutics Provides Strategic Update (EQS Group)
04.11.22	Kinarus Therapeutics Provides Strategic Update (EQS Group)
04.11.22	Kinarus Therapeutics Provides Strategic Update (GlobeNewswire)
30.09.22	Kinarus Therapeutics Announces Discontinuation of the Phase 2 KINETIC Study of KIN001 in Hospitalized COVID-19 Patients Following a Prespecified Interim Analysis of Efficacy and Safety (GlobeNewswire)
25.08.22	Edison Investment Research Limited: Kinarus Therapeutics (KNRS): Initiation - A unique combination targeting unmet needs (EQS Group)
22.08.22	Kinarus Therapeutics to hold webinar on a new approach to treating COVID-19 (GlobeNewswire)
22.08.22	Kinarus announces the issuance of convertible notes of up to CHF 20 million to an entity managed by Yorkville (GlobeNewswire)

Newssuche

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Logitech Intl	79.88	2.70 %	K V
Roche Hldg G	264.40	2.68 %	K V
Lonza Grp	554.20	2.29 %	K V
Swiss Re	134.85	1.70 %	K V
Novartis	90.39	1.61 %	K V
ABB	49.48	-0.26 %	K V
Geberit	513.60	-0.35 %	K V
Sika	216.90	-0.37 %	K V
Kuehne+Nagel Int	208.50	-0.43 %	K V
Holcim	88.08	-0.45 %	K V

mehr

25.04.24		Verluste in Zürich: SPI leichter
25.04.24		SPI-Handel aktuell: SPI leichter
24.04.24		Verluste in Zürich: SPI verbucht letztendlich Abschläge
23.04.24		Freundlicher Handel in Zürich: So bewegt sich der SPI am Dienstagnachmittag
23.04.24		Börse Zürich: So steht der SPI am Mittag
23.04.24		Optimismus in Zürich: SPI beginnt Dienstagssitzung in der Gewinnzone
22.04.24		Zuversicht in Zürich: SPI klettert schlussendlich
22.04.24		Handel in Zürich: SPI am Montagmittag in der Gewinnzone